The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β
Open accessAbstract
We have analysed the interactions of three proteoglycans of the decorin family, decorin, biglycan and fibromodulin, with transforming growth factor beta (TGF-beta). The proteoglycan core proteins, expressed from human cDNAs as fusion proteins with Escherichia coli maltose-binding protein, each bound TGF-beta 1. They showed only negligible binding to several other growth factors. Intact decorin, biglycan and fibromodulin isolated from bovine tissues competed with the fusion proteins for the TGF-beta binding. Affinity measurements suggest a two-site binding model with Kd values ranging from 1 to 20 nM for a high-affinity binding site and 50 to 200 nM for the lower-affinity binding site. The stoichiometry indicated that the high-affinity binding site was present in one of ten proteoglycan core molecules and that each molecule contained a low-affinity binding site. Tissue-derived biglycan and decorin were less effective competitors for TGF-beta binding than fibromodulin or the non-glycosylated fusion proteins; removal of the chondroitin/dermatan sulphate chains of decorin and biglycan (fibromodulin is a keratan sulphate proteoglycan) increased the activities of decorin and biglycan, suggesting that the glycosaminoglycan chains may hinder the interaction of the core proteins with TGF-beta. The fusion proteins competed for the binding of radiolabelled TGF-beta to Mv 1 Lu cells and endothelial cells. Affinity labelling showed that the binding of TGF-beta to betaglycan and the type-I receptors in Mv 1 Lu cells and to endoglin in endothelial cells was reduced, but the binding to the type-II receptors was unaffected. TGF-beta 2 and 3 also bound to all three fusion proteins. Latent recombinant TGF-beta 1 precursor bound slightly to fibromodulin and not at all to decorin and biglycan. The results show that the three decorin-type proteoglycans each bind TGF-beta isoforms and that slight differences exist in their binding properties. They may regulate TGF-beta activities by sequestering TGF-beta into extracellular matrix.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
PCR protocols — A guide to methods and applications
U.G. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90252-7 · Cited by 11,702
LIGAND: A versatile computerized approach for characterization of ligand-binding systems
Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,429
Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P., & Ornitz, D. M. (1991) · Cell · doi:10.1016/0092-8674(91)90512-w · Cited by 2,440
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Negative regulation of transforming growth factor-β by the proteoglycan decorin
Yamaguchi, Y., Mann, D. M., & Ruoslahti, E. (1990) · Nature · doi:10.1038/346281a0 · Cited by 1,516
Self-citationRequirement of Heparan Sulfate for bFGF-Mediated Fibroblast Growth and Myoblast Differentiation
Rapraeger, A. C., Krufka, A., & Olwin, B. B. (1991) · Science · doi:10.1126/science.1646484 · Cited by 1,508
Proteoglycans as modulators of growth factor activities
Ruoslahti, E., & Yamaguchi, Y. (1991) · Cell · doi:10.1016/0092-8674(91)90308-l · Cited by 1,343
Self-citationA heparin-binding growth factor secreted by macrophage-like cells that is related to EGF
Higashiyama, S., Abraham, J. A., Miller, J., Fiddes, J. C., & Klagsbrun, M. (1991) · Science · doi:10.1126/science.1840698 · Cited by 1,127
Cited by
MATRIX PROTEOGLYCANS: From Molecular Design to Cellular Function
Iozzo, R. V. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.609 · Cited by 1,637
Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility
Danielson, K. G., Baribault, H., Holmes, D. F., Graham, H., Kadler, K. E., & Iozzo, R. V. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.136.3.729 · Cited by 1,406
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Kim, S.-H., Turnbull, J., & Guimond, S. (2011) · Journal of Endocrinology · doi:10.1530/joe-10-0377 · Cited by 1,166
Muscle Injuries: Biology and Treatment
Järvinen, T. A. H., Järvinen, T. L. N., Kääriäinen, M., Kalimo, H., & Järvinen, M. (2005) · The American Journal of Sports Medicine · doi:10.1177/0363546505274714 · Cited by 1,072
Sime, P. J., Xing, Z., Graham, F. L., Csaky, K. G., & Gauldie, J. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119590 · Cited by 1,050
Extracellular Matrix and Dermal Fibroblast Function in the Healing Wound
Tracy, L. E., Minasian, R. A., & Caterson, E. J. (2016) · Advances in Wound Care · doi:10.1089/wound.2014.0561 · Cited by 1,008
“chondroitin and dermatan side chains.(114) In this way, decorin can act as a natural inhibitor of TGFb1 and is associated with decreased fibrosis and formation of normal scars.”
BackgroundSchaefer, L., Babelova, A., Kiss, E., Hausser, H.-J., Baliova, M., Krzyzankova, M., Marsche, G., Young, M. F., Mihalik, D., Götte, M., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23755 · Cited by 850
The myofibroblast matrix: implications for tissue repair and fibrosis
Klingberg, F., Hinz, B., & White, E. S. (2013) · The Journal of Pathology · doi:10.1002/path.4104 · Cited by 776
The molecular basis of lung morphogenesis
Warburton, D., Schwarz, M., Tefft, D., Flores-Delgado, G., Anderson, K. D., & Cardoso, W. V. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00325-1 · Cited by 729
The Biology of the Small Leucine-rich Proteoglycans
Iozzo, R. V. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.27.18843 · Cited by 645
Iozzo, R. V., & Murdoch, A. D. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.5.8621059 · Cited by 642
Transforming growth factor βs and wound healing
O'Kane, S., & Ferguson, M. W. J. (1997) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(96)00120-3 · Cited by 634
Protein Repeats: Structures, Functions, and Evolution
Andrade, M. A., Perez-Iratxeta, C., & Ponting, C. P. (2001) · Journal of Structural Biology · doi:10.1006/jsbi.2001.4392 · Cited by 615
Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice
Xu, T., Bianco, P., Fisher, L. W., Longenecker, G., Smith, E., Goldstein, S., Bonadio, J., Boskey, A., Heegaard, A.-M., Sommer, B., et al. (1998) · Nature Genetics · doi:10.1038/1746 · Cited by 612
Extracellular Matrix Molecules: Potential Targets in Pharmacotherapy
Järveläinen, H., Sainio, A., Koulu, M., Wight, T. N., & Penttinen, R. (2009) · Pharmacological Reviews · doi:10.1124/pr.109.001289 · Cited by 566
Biological Functions of the Small Leucine-rich Proteoglycans: From Genetics to Signal Transduction
Schaefer, L., & Iozzo, R. V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800020200 · Cited by 549
Proteoglycans: from structural compounds to signaling molecules
Schaefer, L., & Schaefer, R. M. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0821-y · Cited by 548
VEGF145, a Secreted Vascular Endothelial Growth Factor Isoform That Binds to Extracellular Matrix
Poltorak, Z., Cohen, T., Sivan, R., Kandelis, Y., Spira, G., Vlodavsky, I., Keshet, E., & Neufeld, G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.11.7151 · Cited by 519
Iozzo, R. V. (1997) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239709108551 · Cited by 498
Leucine-rich repeat glycoproteins of the extracellular matrix
Hocking, A. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90070-1 · Cited by 470
Kizawa, H., Kou, I., Iida, A., Sudo, A., Miyamoto, Y., Fukuda, A., Mabuchi, A., Kotani, A., Kawakami, A., Yamamoto, S., et al. (2005) · Nature Genetics · doi:10.1038/ng1496 · Cited by 468
Induction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
BUCKWALTER, J. A., & MANKIN, H. J. (1997) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199704000-00021 · Cited by 464
Dermatan sulfate: new functions from an old glycosaminoglycan
Trowbridge, J. M., & Gallo, R. L. (2002) · Glycobiology · doi:10.1093/glycob/cwf066 · Cited by 457
Scarless Fetal Wound Healing: A Basic Science Review
Larson, B. J., Longaker, M. T., & Lorenz, H. P. (2010) · Plastic and Reconstructive Surgery · doi:10.1097/prs.0b013e3181eae781 · Cited by 454
Inflammation in intervertebral disc degeneration and regeneration
Molinos, M., Almeida, C. R., Caldeira, J., Cunha, C., Gonçalves, R. M., & Barbosa, M. A. (2015) · Journal of The Royal Society Interface · doi:10.1098/rsif.2014.1191 · Cited by 454
IMAI, K., HIRAMATSU, A., FUKUSHIMA, D., PIERSCHBACHER, M. D., & OKADA, Y. (1997) · Biochemical Journal · doi:10.1042/bj3220809 · Cited by 445
Ameye, L., & Young, M. F. (2002) · Glycobiology · doi:10.1093/glycob/cwf065 · Cited by 431
Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts
Dallas, S. L., Rosser, J. L., Mundy, G. R., & Bonewald, L. F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111663200 · Cited by 414
Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
Robertson, I. B., & Rifkin, D. B. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a021907 · Cited by 403
Extracellular Matrix in Kidney Fibrosis: More Than Just a Scaffold
Bülow, R. D., & Boor, P. (2019) · Journal of Histochemistry & Cytochemistry · doi:10.1369/0022155419849388 · Cited by 406
The role of decorin in collagen fibrillogenesis and skin homeostasis
Reed, C. C., & Iozzo, R. V. (2002) · Glycoconjugate Journal · doi:10.1023/a:1025383913444 · Cited by 398
Proteoglycans of the extracellular matrix and growth control
Kresse, H., & Schönherr, E. (2001) · Journal of Cellular Physiology · doi:10.1002/jcp.10030 · Cited by 391
TGF-β in kidney fibrosis: A target for gene therapy
Border, W. A., & Noble, N. A. (1997) · Kidney International · doi:10.1038/ki.1997.190 · Cited by 379
Self-citationStructure and biological activity of the extracellular matrix
Aumailley, M., & Gayraud, B. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050215 · Cited by 369
Myocardial Extracellular Matrix: An Ever-Changing and Diverse Entity
Rienks, M., Papageorgiou, A.-P., Frangogiannis, N. G., & Heymans, S. (2014) · Circulation Research · doi:10.1161/circresaha.114.302533 · Cited by 366
Haslett, J. N., Sanoudou, D., Kho, A. T., Bennett, R. R., Greenberg, S. A., Kohane, I. S., Beggs, A. H., & Kunkel, L. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192571199 · Cited by 364
Tsukada, S., Parsons, C. J., & Rippe, R. A. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.06.014 · Cited by 357
Ameye, L., Aria, D., Jepsen, K., Oldberg, A., Xu, T., & Young, M. F. (2002) · The FASEB Journal · doi:10.1096/fj.01-0848com · Cited by 347
Merline, R., Moreth, K., Beckmann, J., Nastase, M. V., Zeng-Brouwers, J., Tralhão, J. G., Lemarchand, P., Pfeilschifter, J., Schaefer, R. M., Iozzo, R. V., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001868 · Cited by 333
Johnston, A., Xing, X., Guzman, A. M., Riblett, M., Loyd, C. M., Ward, N. L., Wohn, C., Prens, E. P., Wang, F., Maier, L. E., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003162 · Cited by 319
Saharinen, J., Hyytiäinen, M., Taipale, J., & Keski-Oja, J. (1999) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(99)00010-6 · Cited by 315
Excessive transforming growth factor-β signaling is a common mechanism in osteogenesis imperfecta
Grafe, I., Yang, T., Alexander, S., Homan, E. P., Lietman, C., Jiang, M. M., Bertin, T., Munivez, E., Chen, Y., Dawson, B., et al. (2014) · Nature Medicine · doi:10.1038/nm.3544 · Cited by 306
Targeting renal fibrosis: Mechanisms and drug delivery systems
Nastase, M. V., Zeng-Brouwers, J., Wygrecka, M., & Schaefer, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.12.019 · Cited by 302
Dynamics of Transforming Growth Factor Beta Signaling in Wound Healing and Scarring
Finnson, K. W., McLean, S., Di Guglielmo, G. M., & Philip, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2013.0429 · Cited by 300
The small leucine‐rich proteoglycan biglycan modulates BMP‐4‐induced osteoblast differentiation
Chen, X.-D., Fisher, L. W., Robey, P. G., & Young, M. F. (2004) · The FASEB Journal · doi:10.1096/fj.03-0899com · Cited by 295
Coating of titanium implants with collagen, RGD peptide and chondroitin sulfate
Rammelt, S., Illert, T., Bierbaum, S., Scharnweber, D., Zwipp, H., & Schneiders, W. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2006.06.034 · Cited by 294
Iozzo, R. V., & Schaefer, L. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07797.x · Cited by 292
van der Kraan, P. M., Buma, P., van Kuppevelt, T., & van Den Berg, W. B. (2002) · Osteoarthritis and Cartilage · doi:10.1053/joca.2002.0806 · Cited by 281
Biological interplay between proteoglycans and their innate immune receptors in inflammation
Frey, H., Schroeder, N., Manon‐Jensen, T., Iozzo, R. V., & Schaefer, L. (2013) · The FEBS Journal · doi:10.1111/febs.12145 · Cited by 274
Demetriou, M., Binkert, C., Sukhu, B., Tenenbaum, H. C., & Dennis, J. W. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12755 · Cited by 272
Regenerative Scar-Free Skin Wound Healing
Monavarian, M., Kader, S., Moeinzadeh, S., & Jabbari, E. (2019) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2018.0350 · Cited by 271
Kolb, M., Margetts, P. J., Sime, P. J., & Gauldie, J. (2001) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2001.280.6.l1327 · Cited by 270
Extracellular Matrix and Cytokines: A Functional Unit
Schönherr, E., & Hausser, H.-J. (2000) · Journal of Immunology Research · doi:10.1155/2000/31748 · Cited by 268
Lyon, M., Rushton, G., & Gallagher, J. T. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.29.18000 · Cited by 258
Matrix control of transforming growth factor- function
Horiguchi, M., Ota, M., & Rifkin, D. B. (2012) · Journal of Biochemistry · doi:10.1093/jb/mvs089 · Cited by 258
Characterization of collagens and proteoglycans at the insertion of the human achilles tendon
Waggett, A. D., Ralphs, J. R., Kwan, A. P. L., Woodnutt, D., & Benjamin, M. (1998) · Matrix Biology · doi:10.1016/s0945-053x(98)90017-8 · Cited by 257
Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal Cells
Bi, Y., Stuelten, C. H., Kilts, T., Wadhwa, S., Iozzo, R. V., Robey, P. G., Chen, X.-D., & Young, M. F. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500573200 · Cited by 256
Ang, L. S., Boivin, W. A., Williams, S. J., Zhao, H., Abraham, T., Carmine-Simmen, K., McManus, B. M., Bleackley, R. C., & Granville, D. J. (2011) · Cell Death & Disease · doi:10.1038/cddis.2011.88 · Cited by 55
Mochida, Y., Parisuthiman, D., Kaku, M., Hanai, J.-I., Sukhatme, V. P., & Yamauchi, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604787200 · Cited by 34
Haga, M., Iida, K., & Okada, M. (2024) · iScience · doi:10.1016/j.isci.2024.109708 · Cited by 19
Metadata
- Authors
- Hildebrand, A., Romarís, M., Rasmussen, L. M., Heinegård, D., Twardzik, D. R., Border, W. A., & Ruoslahti, E.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1994-09-01
- Volume
- 302
- Issue
- 2
- Pages
- 527-534
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1544527238
- Cited by
- 994
- References
- 48
- FWCI
- 6.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.